▶주메뉴 바로가기
▶본문 바로가기
Samsung Epis Holdings has opened its first overseas research and development office in Beijing, looking to leverage the local talent and infrastructure to speed up new drug discovery. According to Samsung Epis Holdings on Wednesday, it held an official opening ceremony for Samsung Bioepis China on the previous day. In May, the firm announced that it had recently set up Samsung Bioepis China, a fully owned subsidiary, in Beijing’s Changping district, without disclosing the size of the investment.
Genewel, the life sciences arm of Dongsung Chemical, said Tuesday it hosted a product presentation and surgery observation session for Indonesian pharmaceutical company Pyridam Farma to showcase its postoperative pain management device, Welpass. The event featured a product presentation by Cho Jong-ho, professor of thoracic surgery at Samsung Medical Center, and a live surgery observation session led by Seong Yong-won, professor of thoracic and cardiovascular surgery at SMG-SNU Boramae Medical C
LG Chem said Tuesday it has received US Food and Drug Administration clearance for its investigational new drug application to begin a phase 1/2 clinical trial of LG00313112, an anticancer drug candidate. LG00313112, licensed from Frontier Medicines in April last year, targets TP53 Y220C, a mutation found in 1 to 3 percent of cancer patients. The drug is designed to stabilize the structurally unstable p53 protein caused by the mutation and restore its tumor-suppressing function. LG Chem said the
SAN DIEGO — Inside the social room on the second floor of a building at Lilly Gateway Labs in San Diego, researchers and scientists gathered in separate groups, casually discussing ongoing projects or sharing lunchtime conversation on Thursday. Next door to the spacious, comfortable social room was a module — a combination of an office space and a laboratory — of a resident biotechnology firm. "Our philosophy is that the access to our scientific leadership and expertise is just as valuable as th
Samsung Biologics’ labor union has voted to leave the Samsung Group-wide super-enterprise union and shift to an independent company-level structure, as prolonged wage talks with management remain stalled. The Samsung Biologics branch said Sunday that members approved the organizational change in a vote held from Wednesday. Of 4,005 eligible members, 2,479 voted, with 2,392, or 96.5 percent, in favor. The exit comes as the Samsung Biologics union has struggled to make progress in wage and collect
SAN DIEGO — Celltrion has expanded its global partnering efforts with its artificial intelligence-powered drug discovery capabilities and next-generation biologics pipeline at the BIO International Convention 2026 in San Diego this week, the Korean biosimilar company said Thursday. This year’s convention, arguably the world’s largest biopharmaceutical and biotechnology showcase, drew approximately 20,000 participants from more than 68 countries, including over 1,600 exhibitors. Celltrion reporte
SAN DIEGO — Samsung Biologics is accelerating research and development efforts to strengthen its position in the contract development and manufacturing organization market by leveraging proprietary platforms, next-generation modalities and strategic technology investments. “Supporting core technology for contract development business is the most important task at (Samsung Biologics’ Bio R&D Center),” Jeong Hyeong-nam, chief of Samsung Biologics’ Bio R&D Center, said at press conference at the BI
SAN DIEGO — Lotte Biologics is zeroing in on securing more orders and expanding its global presence with the completion of Plant 1’s construction and approval for use at its Songdo Bio Campus in Incheon. “Lotte Biologics has now secured a dual-site production system in the United States and Korea,” said James Park, CEO of Lotte Biologics, in a press conference on the sidelines of the BIO International Convention in San Diego on Tuesday. “Based on the Songdo Bio Campus’ Plant 1 and the Syracuse B
The Korea Exchange hosted an investor outreach event for global biotech companies at BIO International Convention 2026 in San Diego on Tuesday, stepping up efforts to attract overseas firms to Korea's capital market. BIO International Convention is the world's largest biotechnology exhibition, drawing about 20,000 participants from 72 countries last year. Co-hosted with Invest Seoul, the event introduced the Kosdaq listing process for foreign companies and key initial public offering requirement
STEM CELL PROCESSING SYSTEM MIRACELL SMART M-CELL Stem cell technology firm Miracell has secured US Food and Drug Administration 510(k) clearance for its integrated cell-processing system, marking a significant milestone in the company's efforts to expand its presence in the global regenerative medicine market. The FDA granted 510(k) clearance in April for a system comprising the Smart M-Cell cell concentration device, the BSC blood kit and the BmSC bone marrow kit. The clearance followed a subs
Chipotle bets on Korea for first bite of Asia
Samsung vs. LG battle for AI cooling heats up
Musinsa posts record earnings on offline, global expansion
One purchase every 0.9 second: Olive Young foreign sales top W1tr
Samsung, SK hynix tax payments surge 167% on chip boom
SK Chemicals eyes European can-coating market
Sept. 2, 2026
July 1, 2026
June 30, 2026
June 30, 2026
June 29, 2026
June 28, 2026![[Bio USA] Celltiron posts record showing at BIO International Convention](https://wimg.heraldcorp.com/news/cms/2026/06/26/news-p.v1.20260626.18667da58aa840e9825a821d32e3b03c_T1.jpg?type=h&h=240)
June 26, 2026![[Bio USA] Samsung Biologics steps up CDMO tech race](https://wimg.heraldcorp.com/news/cms/2026/06/25/news-p.v1.20260625.f51e49aea91645fb84edbcfa66d25062_T1.png?type=h&h=240)
June 25, 2026![[Bio USA] Lotte Biologics eyes more CDMO orders with Songdo Plant 1](https://wimg.heraldcorp.com/news/cms/2026/06/25/news-p.v1.20260625.90145400a2be4bcfb3d2d00a858889f7_T1.png?type=h&h=240)
June 25, 2026![[Bio USA] Korea Exchange courts global biotech IPOs at Bio USA](https://wimg.heraldcorp.com/news/cms/2026/06/25/news-p.v1.20260625.6d1c452fae55415d9e335932a19def55_T1.jpg?type=h&h=240)
June 25, 2026![[Best Brand] Miracell secures FDA 510(k) clearance for stem cell processing system](https://wimg.heraldcorp.com/news/cms/2026/06/24/news-p.v1.20260623.5be91df146c14926a929466a795841fd_T1.png?type=h&h=240)
June 24, 2026
